Provided by Tiger Fintech (Singapore) Pte. Ltd.

Quantum Biopharma Ltd.

7.18
+2.2946.83%
Post-market: 7.780.6000+8.36%19:59 EDT
Volume:8.50M
Turnover:66.62M
Market Cap:13.84M
PE:-0.56
High:8.60
Open:5.57
Low:5.28
Close:4.89
Loading ...

Quantum BioPharma Unaware of Any Material Change

Newsfile
·
11 hours ago

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial

TipRanks
·
14 Mar

Quantum BioPharma Provides Corporate Update

Newsfile
·
08 Mar

Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302

GlobeNewswire
·
26 Feb

Quantum BioPharma Continues to Diversify its Treasury with the Purchase of Another USD $1,000,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies

GlobeNewswire
·
18 Feb

Quantum Biopharma (QNTM) Generating A Significant Buzz with Shares Up 230% YTD

TIPRANKS
·
12 Feb

Quantum Biopharma Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

GlobeNewswire
·
11 Feb

Quantum Biopharma Engages Enterprise Canada and Empire Market Ventures to Lead Public Communications and Investor Awareness Programs

GlobeNewswire
·
10 Feb

Dow Edges Higher; US Weekly Jobless Claims Increase

Benzinga
·
06 Feb

QNTM Stock trading resumes

TIPRANKS
·
06 Feb

QNTM Stock trading halted, volatility trading pause

TIPRANKS
·
06 Feb

Quantum Biopharma Licensee Celly Nutrition Retains Leading New York Investment Bank to Advise on Capital Raise and Possible Initial Public Offering Following Highly Positive Results from unbuzzd™ Clinical Study

GlobeNewswire
·
06 Feb

Gold Moves Higher; Estée Lauder Shares Slide

Benzinga
·
05 Feb

Quantum BioPharma's Unbuzzd Proven to Accelerate Alcohol Metabolism in Clinical Trial; Shares Jump

MT Newswires Live
·
04 Feb

US Stocks Mixed; PepsiCo Posts Downbeat Sales

Benzinga
·
04 Feb

Investor Sentiment Muted Amid China's Retaliatory Tariffs, Stifling US Equity Futures Pre-Bell

MT Newswires Live
·
04 Feb